Equitable Holdings Inc. Buys Shares of 2,156 Astera Labs, Inc. $ALAB

Equitable Holdings Inc. purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the second quarter, Holdings Channel.com reports. The fund purchased 2,156 shares of the company’s stock, valued at approximately $1,041,000.

Several other hedge funds have also made changes to their positions in ALAB. Reflection Asset Management purchased a new stake in Astera Labs during the 4th quarter worth approximately $25,000. Keating Financial Advisory Services Inc. acquired a new stake in Astera Labs during the 2nd quarter worth approximately $25,000. Smartleaf Asset Management LLC lifted its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in Astera Labs in the 4th quarter valued at approximately $33,000. Finally, Whipplewood Advisors LLC boosted its position in Astera Labs by 15,950.0% in the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 4.8%

Shares of NASDAQ:ALAB opened at $289.47 on Friday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company’s 50 day moving average is $342.38 and its two-hundred day moving average is $249.65. The company has a market cap of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the previous year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on ALAB shares. Jefferies Financial Group upped their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Royal Bank Of Canada boosted their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Evercore restated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. UBS Group reaffirmed a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Barclays lifted their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $340.53.

Insider Buying and Selling

In other news, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the transaction, the director owned 3,970 shares in the company, valued at approximately $1,237,965.10. The trade was a 69.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 419,244 shares of company stock valued at $163,135,169 over the last 90 days. 10.40% of the stock is currently owned by corporate insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.